Kangfang Biotech (09926.HK) plans to allocate approximately 23.55 million shares of primary placement shares.

Wise Finance News APP, Confo Bio (09926.HK) announced that the placement agent has conditionally agreed to place or cause to be placed 23.55 million first-level placement shares at a placement price of 149.54 Hong Kong dollars per share during the placement period (or else the placement agent will purchase on its own behalf as the principal).